Deadly meningitis outbreak tied to more drugs, FDA says
Bloomberg, October 16, 2012
A second steroid manufactured by New England Compounding Center has been linked to another potential meningitis infection, U.S. regulators said. The second steroid, triamcinolone acetonide, is used to treat skin conditions that result in itching, redness, dryness, and inflammation, according to the National Institutes of Health. The patients received the medication through an epidural injection. Transplant patients have also experienced fungal infections after being given a drug from the pharmacy meant to induce cardiac muscle paralysis during open-heart surgery, the Food and Drug Administration said.
Most Viewed
Most Emailed
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Building a Better Healthcare Board
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- Case Study: Advance Care Conversations
- Quiet ORs Better for Patient Safety
- Hard-Nosed About Physician Teamwork
- Tavenner Confirmed as CMS Administrator
- CMS Releases Hospital Pricing Data
- Hospital Pricing Data Dump Won't Hurt You, Yet
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
